GNH USA

Europe — EMA

Mucocis (Carbocisteine)

GNH USA supplies Mucocis (Carbocisteine), a mucolytic agent for chronic bronchitis, COPD and productive cough. Request a quote for global supply today.

Carbocisteine

Request sourcing

1
Pack/s

What is Carbocisteine?

Carbocisteine, the active ingredient in Mucocis, is a mucolytic agent presented as an oral formulation for oral use. It helps reduce thick mucus in the airways of patients with chronic bronchitis, COPD, and productive cough with thick mucus.

GNH USA supplies Mucocis as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Carbocisteine used for?

Carbocisteine is used as a mucolytic to facilitate clearance of airway secretions in respiratory conditions.

Chronic bronchitis: improves mucus clearance and reduces cough frequency. COPD: thins sputum to ease expectoration and improve breathing. Productive cough with thick mucus: reduces viscosity of secretions to aid expectoration.

What are the side effects of Carbocisteine?

Carbocisteine may cause several adverse reactions.

Common Side Effects: - Nausea - Vomiting - Diarrhoea - Abdominal discomfort - Taste disturbance - Skin rash

Serious or Rare Side Effects: - Anaphylactic reaction - Stevens‑Johnson syndrome or severe skin eruptions - Hepatic dysfunction - Neutropenia - Bronchospasm - Hematuria

What precautions apply to Carbocisteine?

When prescribing carbocisteine, consider the following precautions.

Renal impairment: dose may need adjustment in severe renal dysfunction. Hepatic disease: monitor liver function as metabolism may be affected. Pregnancy and lactation: safety not established; use only if benefit outweighs risk. Concomitant mucolytics: avoid duplicate therapy to prevent excess mucus thinning. Store at ambient temperature: keep below 25°C, retain original packaging, protect from moisture.

What does Carbocisteine interact with?

Carbocisteine can interact with other medicines; monitor patients accordingly.

Major Interactions (Avoid): - Antitussives containing codeine: may counteract mucolytic effect. - Bronchodilators with high anticholinergic activity: may increase risk of dry mouth.

Moderate Interactions (Monitor Closely): - Macrolide antibiotics: may increase carbocisteine plasma levels. - Corticosteroids: monitor for additive gastrointestinal irritation. - Alcohol: may enhance gastrointestinal side effects.

Frequently asked questions

What conditions is Mucocis used to treat?+
Mucocis contains carbocisteine, a mucolytic indicated for chronic bronchitis, COPD, and productive cough with thick mucus. It helps thin secretions, facilitating clearance of airway mucus and reducing cough severity.
How does carbocisteine work?+
Carbocisteine reduces mucus viscosity by breaking disulfide bonds in mucopolysaccharide chains. This makes secretions less thick, allowing ciliary motion and coughing to more efficiently clear airway secretions.
What is the usual dose of Mucocis?+
The prescribed dose of carbocisteine is determined by the treating physician based on the patient’s age, severity of symptoms and renal function. Dosage forms and regimens vary, and the prescriber sets the appropriate schedule.
Is Mucocis safe during pregnancy or breastfeeding?+
Safety data for carbocisteine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified health professional.
How do I order Mucocis from GNH USA?+
To place an order, submit an enquiry on the Mucocis product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Mucocis compare with other mucolytics?+
Carbocisteine differs from agents such as acetylcysteine by primarily breaking disulfide bonds in mucus rather than acting as a direct antioxidant. It is generally well‑tolerated and may be preferred when a gentler mucolytic effect is desired, though clinical choice depends on patient factors and physician judgment.
What are the recommended storage conditions for Mucocis?+
Mucocis should be stored at ambient temperature, preferably below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and heat sources to maintain stability.
How is Mucocis administered?+
Mucocis is taken orally, usually with a glass of water. The tablet or liquid should be swallowed whole and not chewed, unless the specific dosage form advises otherwise. Administration timing (e.g., with meals) is guided by the prescribing clinician.
What are the most serious risks associated with carbocisteine?+
Although uncommon, serious adverse reactions can include severe allergic responses such as anaphylaxis, skin reactions like Stevens‑Johnson syndrome, hepatic dysfunction, neutropenia and bronchospasm. Patients should seek immediate medical attention if they experience any of these symptoms.
Who should not use Mucocis?+
Individuals with known hypersensitivity to carbocisteine or any excipients in the product should avoid Mucocis. Caution is also advised for patients with severe renal or hepatic impairment, and it should not be used in pregnant or breastfeeding women unless clearly indicated by a physician.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Carbocisteine
Route
Oral Use
Manufacturer
So.Se.Pharm S.R.L.
Origin
EU

Related products

Actithiol Mucolítico Infantil

Actithiol Mucolítico Infantil

Carbocisteine

Almirall, S.A.
EU
Auropect

Auropect

Carbocisteine

Aurovitas Pharma Polska Sp. Z O.O
EU
Auropect Comfort

Auropect Comfort

Carbocisteine

Aurovitas Pharma Polska Sp. Z O.O
EU
Benylin Mucus Relief

Benylin Mucus Relief

Carbocisteine

Jntl Consumer Health I (Ireland) Limited
EU